Veraxa Biotech Holding AG
VRXANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for VRXA. That does not mean none is planned.
Get an email about VRXA's next catalysts
Track Veraxa Biotech Holding (VRXA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
How VRXA's past catalysts played out
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VY7523 | Phase 2 | Alzheimer's Disease (AD) | - | - |
Frequently asked questions
What is in Veraxa Biotech Holding AG's drug pipeline?β
CatalystAlert tracks 1 drug candidate in Veraxa Biotech Holding AG's (VRXA) pipeline across Phase 2. Its lead program is VY7523 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Veraxa Biotech Holding AG's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Veraxa Biotech Holding AG (VRXA) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track VRXA biotech catalysts?β
Add VRXA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Veraxa Biotech Holding AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
